KLRC2 and myeloid sarcoma: A recent study showed reduced expression of FoxP3 and CD122 in NKG2C-expressing CD8+ T-cells from MS patients compared to healthy controls, suggesting a reduced regulatory potential of these cells in MS patients (41).